IGF2BP3-silenced HCC cells showed significantly reduced expression of the EIF5B mRNA; moreover, the half-life of the EIF5B mRNA was significantly shortened in the IGF2BP3-silenced HCC cells compared to the controls (Fig. 7F). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.